Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | -9 | 0 | 265 |
| Cost of Goods | N/A | N/A | 1,291 | 8,400 | 1,344 |
| Gross Profit | N/A | N/A | -1,300 | -8,400 | -1,079 |
| Operating Expenses | 10,227 | 9,562 | 7,736 | 10,025 | 13,279 |
| Operating Income | -10,227 | -9,562 | -8,745 | -18,025 | -14,014 |
| Other Income | 317 | -239 | -452 | -14 | 18 |
| Pre-tax Income | -9,910 | -9,801 | -9,197 | -18,039 | -13,996 |
| Net Income Continuous | -9,910 | -9,801 | -9,197 | -18,039 | -13,996 |
| Net Income | $-9,910 | $-9,801 | $-9,197 | $-18,039 | $-13,996 |
| EPS Basic Total Ops | -0.22 | -0.26 | -0.21 | -0.49 | -0.44 |
| EPS Basic Continuous Ops | -0.22 | -0.26 | -0.21 | -0.49 | -0.44 |
| EPS Diluted Total Ops | -0.22 | -0.26 | -0.21 | -0.49 | -0.44 |
| EPS Diluted Continuous Ops | -0.22 | -0.26 | -0.21 | -0.49 | -0.44 |
| EBITDA(a) | $-9,925 | $-9,260 | $-8,409 | $-17,686 | $-13,660 |